Tributary Capital Management LLC Increases Holdings in Simulations Plus, Inc. (NASDAQ:SLP)

Tributary Capital Management LLC raised its holdings in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 21.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 396,093 shares of the technology company’s stock after acquiring an additional 70,526 shares during the quarter. Tributary Capital Management LLC’s holdings in Simulations Plus were worth $11,047,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the business. First Horizon Advisors Inc. boosted its holdings in Simulations Plus by 82.6% in the third quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company’s stock valued at $26,000 after purchasing an additional 370 shares in the last quarter. nVerses Capital LLC boosted its holdings in shares of Simulations Plus by 1,100.0% in the 3rd quarter. nVerses Capital LLC now owns 1,200 shares of the technology company’s stock valued at $38,000 after buying an additional 1,100 shares in the last quarter. Quantbot Technologies LP purchased a new position in shares of Simulations Plus in the 3rd quarter valued at $59,000. US Bancorp DE raised its stake in Simulations Plus by 37.0% during the 3rd quarter. US Bancorp DE now owns 4,974 shares of the technology company’s stock worth $159,000 after acquiring an additional 1,343 shares in the last quarter. Finally, The Manufacturers Life Insurance Company raised its stake in Simulations Plus by 7.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 6,391 shares of the technology company’s stock worth $311,000 after acquiring an additional 456 shares in the last quarter. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Simulations Plus Price Performance

Simulations Plus stock opened at $33.78 on Friday. The business has a 50 day simple moving average of $29.95 and a 200-day simple moving average of $32.89. Simulations Plus, Inc. has a 12 month low of $24.00 and a 12 month high of $51.22. The stock has a market capitalization of $678.64 million, a PE ratio of 84.45 and a beta of 0.80.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. The company had revenue of $18.70 million during the quarter, compared to the consensus estimate of $19.73 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. Simulations Plus’s quarterly revenue was up 19.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.18 EPS. As a group, equities research analysts anticipate that Simulations Plus, Inc. will post 1.09 EPS for the current year.

Insider Transactions at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction on Friday, November 1st. The shares were sold at an average price of $27.66, for a total transaction of $553,200.00. Following the sale, the director now directly owns 3,462,584 shares in the company, valued at approximately $95,775,073.44. The trade was a 0.57 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 19.40% of the company’s stock.

Analyst Ratings Changes

SLP has been the subject of several research analyst reports. William Blair restated an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, January 8th. KeyCorp raised their price target on Simulations Plus from $35.00 to $37.00 and gave the stock an “overweight” rating in a research note on Friday. StockNews.com cut Simulations Plus from a “hold” rating to a “sell” rating in a research note on Monday, November 4th. BTIG Research decreased their price objective on Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a report on Thursday, October 24th. Finally, Stephens began coverage on shares of Simulations Plus in a report on Friday, November 15th. They issued an “overweight” rating and a $39.00 target price on the stock. One analyst has rated the stock with a sell rating, one has issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $49.40.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.